Cancer Talks-2012

Molecular Imaging Seminar Dec 2012 Dr. Rao Papineni : Imaging in vivo ROS Activity in Inflammation and Cancer

3rd International Cancer Research Symposium 2012

Defining & Translating Science for Disease Prevention and Therapy

Venue: SWISSOTEL

Plot No. 11/5, Action Area 2-D, New Town, Rajarhat, Kolkata-700157, West Bengal, India

19 - 21 December, 2012 Topics to be addressed :

(a) Application of Emerging Technologies in Cancer Research (b) Genetic and Epigenetic Mechanisms in the Pathobiology of Cancer (c) Novel Therapies (Immuno-and Stem Cell-based Therapies) (d) Complementary and Alternative Approaches for Cancer Prevention and Therapy

Organizing Committee (USA) Sushanta K. Banerjee (Chair)

C.V.Rao ,(Co-Chair) Rajesh Agarwal , (Co-Chair) Shivendra Singh , (Co-Chair)

Organizing Committee (India)

Dhrubajyoti Chattopadhyay (Chair) Gopal Kundu (Co Chair) Bhudev C Das (Co-Chair)

Secretaries Organizing Committee Gaurisankar Sa (Secretary)

Urmi Chatterji (Secretary)

Treasurer Alok Kumar Sil

Nitai Bhattacharyya Tanya Das Chinmay Panda Deepak Mishra

Sharmila Sengupta Mrinal Ghosh Diptendra Sarkar

Contact USA INDIA

Joi Wickliffe [email protected] Tel: 816-861-4700x57922

Atanu Roy Chowdhury [email protected] Tel: 2335-0067

3rd International Cancer Research Symposium 2012

Defining & Translating Science for Disease Prevention and Therapy 19-21 December, 2012

Plot No. 11/5, Action Area 2-D, New Town, Rajarhat Kolkata, West Bengal 700157, India

The Registration Fee (along with the Registration Form) has to be paid as follows:

• Payment through Demand Draft, multicity account payee cheque or Money Transfer / National Electronic Fund Transfer (NEFT/RTGS) only. • Demand draft or multicity account payee cheque should be drawn in favour of “3rd ICRS 2012” payable at Kolkata (Registration will be confirmed after realization of cheques). • Money transfer/NEFT/RTGS (Inter-Bank Transfer): State Bank of India, Calcutta University Branch, IFSC Code SBIN0007766, A/C No. 32470598175. • Money transfer can also be done through Internet Banking. • Wire transfer for Foreign Remittance through SWIFT Code SBININBB106 • Please write your name and address on the back of the Bank Draft without fail and also enclose three stamp size photographs

Address for correspondence: Prof. D. J. Chattopadhyay

Director, Centre for Research in Nanoscience and Nanotechnology JD-2, Sector-III, Salt Lake, Kolkata-700 098, West Bengal

Telephone : +91 +033-2335 0067 / Fax : +91 +033-2257 1470 E-mail: [email protected]

Website : http://www.3rdicrs2012.org

Last Date of Registration: 15 October, 2012

Completed registration forms and abstracts (if applicable) should be mailed to: [email protected]

ABSTRACTS should be 2000 characters or less with space and have a title, author’s names (presenting author’s name underlined), place of work, contact telephone number and email address. The abstract should have an Introduction, Material and Methods, Results and a Conclusion Section. The authors should indicate in the registration form whether they prefer to make a Poster or Oral presentation.

3rd International Cancer Research Symposium 2012

Defining & Translating Science for Disease Prevention and Therapy 19-21 December, 2012

Plot No. 11/5, Action Area 2-D, New Town, Rajarhat, Kolkata, West Bengal 700157, India

First name, Surname

Prof./ Dr./ Mr./ Ms. Prefix

Gender Male Female

Faculty/ Clinician

PDF Scholar

Department

Institution Address

City State Country

PIN Tel # Cell #

FAX Email

Indian NRI Foreign Nationality

Category of Participation

NO YES Submitting abstract? If yes, ORAL POSTER

Registration Students and PDFs Faculty and Clinicians

15 October, 2012 Rs. 1,500 Rs. 3,000

Spot registration Rs. 2,500 Rs. 5,000

Invited Speaker Young Scientist Delegate General

NON-VEG VEG Food preference

cv

SPEAKER TITLE

*(TBA-to be announced, presenter has yet to provide a title)

1. Addanki Pratap Kumar , Ph.D (USA)

Translation of complementary and alternate

medicinal modalities from bench to bedside.

2. Adhip N Majumdar, Ph.D. (USA)

Cancer Stem Cells: Implications for Colorectal

Carcinogenesis and Development of Therapeutic

Strategies

3. Ajay Rana, Ph.D. (USA)

Mixed Lineage Kinases: Novel Therapeutic Targets

of Proliferative and Degenerative Diseases

4. Alakananda Basu, Ph.D. (USA)

Targeting AGC Kinases in Breast Cancer

5. Alo Nag, Ph.D. (IND)

Combating Cancer Through Discovery of Novel

Molecular Targets.

6. Alok De, Ph.D. (USA)

Prevents Ovarian Carcinogenesis by Amla

7. Amitava Chatterjee, Ph.D. (IND)

MMP-2 a potential marker of breast cancer

8. Andrew Leask, Ph.D. (CAN)

Managing the microenvironment: matricellular

adhesive proteins as signaling modulators in skin

9. Anuradha Sehrawat, PhD (USA)

Inhibition of Epithelial-Mesenchymal

Transition by Benzyl Isothiocyanate, A

Cruciferous Vegetable-Derived Cancer

Chemopreventive Agent

10. Arun Kumar Sharma, Ph.D. (USA)

Developing selenium based cancer

therapeutics

11. Bandana Chatterjee, Ph.D. (USA)

Targeting Intra tumor Androgen Signaling in

Prostate Cancer via Enzymatic Sulfation: A Nuclear

Receptor-directed Novel Treatment Approach

12. Barbara Dunn, Ph.D. (USA)

Update of Clinical Trials in Breast Cancer

13. Bhudev Das, Ph.D. (IND)

TBA

14. Bimal Ray, Ph.D. (USA)

Targeting a Novel Epigenetic Regulatory

Mechanism for Breast Cancer

15. C.V. Rao, Ph.D. (USA)

Transcriptomic Approaches: Prevention and

Treatment of GI Cancers

16. Chandi Charan Mandal, Ph.D. (USA)

A Cholesterol-lowering Drug Targets

Osteoclastogenic Factors to Prevent Osteolytic

Bone Metastasis of Breast Cancer

17. Chandrani Sarkar, Ph.D. (USA)

TBA

18. Charles Giardina, Ph.D. (USA)

New experimental approaches for identifying

novel colon cancer chemopreventive agents

19. Chendil Damodaran, Ph.D (USA)

Modulating AKT induced Epithelial Mesenchymal

Transition for Prevention and Treatment of Colon

Cancer

20. Chimnay Kumar Panda, Ph.D. (IND)

Molecular analysis of cellular pathways associated

with the development of uterine cervical

carcinoma

21. Dipak Banerjee, Ph.D. (USA-PR)

Tunicamycin Inhibits Angiogenesis and Prevents

Breast Cancer Progression

22. Dipak Sarkar, Ph.D. (USA)

Current Research Work on Role of beta-endorphin

in Cancer Prevention

23. Dulal Panda, Ph.D. (IND)

TBA

24. Ellora Sen, Ph.D. (IND)

Tumor necrosis factor (TNFa) regulates

radioresistance in glioblastoma

25. Ernest Hawk, MD (USA)

Clinical Agent Development for CRC Prevention.

26. Gopal Chakrabarti, Ph.D. (IND)

Targeted Drug Development: Synthetic thiadiazole

NMK-TD-100, a novel microtubule modulating

agent, induces apoptosis and autophagy in cancer

cells.

27. Gopal Kundu, Ph.D. (IND) Osteopontin and Related Proteins: Role in

Inflammation, Cancer and Pathological

Angiogenesis

28. Goutam Ghosh–Choudhury, Ph.D.

(USA)

MicroRNAs in renal cancer and tumor suppressor

protein PTEN".

29. Hari Koul, Ph.D. (USA)

Sam Pointed Domain Transcription Factor: A

New Tumor Metastasis Suppressor

30. Jamboor Vishwanatha, Ph.D. (USA)

Reciprocal Regulation of Her-2 and Annexin A2

in Breast Cancer

31. James W. Freeman, Ph.D. (USA)

Molecular Targets for Therapy of the

Chemoresistant/Stem Cell Phenotype in

Pancreatic Cancer.

32. Joan Cunningham, Ph.D. (USA)

Using massage therapy to treat chemotherapy-

induced peripheral neuropathy

33. Kapil Mehta, Ph.D. (USA)

Targeting Inflammation to Prevent Cancer

Progression

34. Kattesh V. Katti, Ph.D. (USA)

How can we achieve tumor staurticity of fast

growing and inoperable metastatic Cancers

35. Lester F. Lau, Ph.D. (USA)

The Matricellular Protein CCN1 in Inflammatory

Diseases and Cancer

36. Lucio Miele, MD, Ph.D. (USA)

Development of Notch inhibitors in breast cancer:

targeting stem cell pathways

37. Mahitosh Mandal (IND)

The potential of celecoxib-loaded hydroxyapatite-

chitosan nanocomposite for the treatment of

colon cancer

38. Mausumi Bharadwaj, Ph.D. (IND)

The genetic and epigenetic regulation of

carcinogenesis in Human Papilloma Virus assoc.

epithelial cancer

39. Michael J. Wargovich, (USA)

Epigenetic Mechanisms in the Chemoprevention

of Colon Cancer by Tea Polyphenol, EGCG

40. Ming You, MD (USA)

TBA

41. Mohamed Saleem (Bhat), Ph.D (USA)

Strategies to Tame the Activities of Androgen

Receptor for Treating Androgen-independent

Prostate Cancer

42. Mrinal Kanti Ghosh, Ph.D. (IND)

Area on basic mechanistic understanding of cancer

cell signaling and crosstalk

43. Nandini Ghsh-Choudhury ,Ph.D. (USA)

Omega 3 Fatty Acids Differentially Target

OncomiRs and Tumor Suppressor micro-RNAs to

Prevent Breast Cancer Metastasis

44. Neil Bhowmick, PhD (USA)

Targeted therapeutics require tumor

microenvironment considerations

45. Nitai P. Bhattacharyya, Ph.D. (IND) TBA

46. Ossama Tawfik, MD, Ph.D. (USA)

What Does a Pap Smear Have to do with

Telepathology? TelePAPology the New Kid on the

Block!!

47. Pamela Munster, MD, Ph.D. (USA)

Reversal of hormone therapy resistance by

epigenetic modulation

48. Partha P. Majumdar, Ph.D. (IND)

GENOMIC ALTERATIONS IN GINGIVO-BUCCAL

ORAL CANCER, IDENTIFIED BY MASSIVELY-

PARALLEL DNA SEQUENCING

49. Peeyush Lala, MD, Ph.D (CAN)

COX-2 and COX-2 induced miRNAs in breast cancer

progression: sustenace of Stem-like cells

50. Peter Van Velduizen, MD (USA)

Prostate Cancer: New Paradigms and

Approaches to Active Surveillance

51. Prasanta Banerji (IND) and Pratip

Banerji ,MD (IND)

The Banerji Protocols: The Regression of Malignant

Tumors by a Non-Toxic and Non-Invasive Oral

Medical Approach

52. Priyabrata Mukherjee , Ph.D. (USA)

Nanomedicine: Opportunities and Challenges in

Cancer Therapy

53. Raj K. Tiwari, Ph.D. (USA)

Cancer Vaccines : Evolving Paradigms

54. Rajagopal Ramesh, Ph.D. (USA)

TUSC2/FUS1-gene-based nanotherapy for lung

cancer: From Mice to Humans

55. Rajendra G. Mehta, Ph.D (USA)

Deguelin as a possible chemopreventive and

therapeutic agent for breast cancer

56. Rajesh Agarwal, Ph.D. (USA)

Epigenetic Mechanisms Contributing to the Anti-

cancer Efficacy of Silibinin in Non-small Cell Lung

Cancer

57. Rajkumar Lakshmanaswamy, Ph.D.

(USA)

Pregnancy, Hormones, and Breast Cancer

58. Rao Papineni, Ph.D. (USA)

Imaging in vivo ROS Activity in Inflammation and

Cancer – A non invasive approach

59. Ratna Chakrabarti , Ph.D. (USA)

Actin cytosketon modulatory protein LIM kinase 1

and functional regulation of MT1-MMP:

Implication in invasion of prostate cancer cells

60. Ratna Ray, Ph.D. (USA)

Prostate Cancer: Potential for Prevention and

Therapy

61. Richard Eckert, Ph.D.(USA)

Polycomb Genes, chemoprevention and skin

cancer response to cell stress

62. Rita Mulherker, Ph.D. (IND)

Gene Therapy for Head and Neck cancer: From lab

to Clinics

63. Robert Sclafani, Ph.D. (USA)

Molecular Mechanism of Cancer Chemoprevention

by Resveratrol.

64. Rod Dashwood (USA)

Epigenetics, diet, and cancer: Convergence of

histone marks, DNA methylation, and miRNA

profiling in chemoprevention studies

65. Roy Jensen, MD (USA)

Overcoming BRCA1 Mediated Chemotherapeutic

and Radiation Resistance in Cancer

66. Samarendra N. Banerjee, Ph.D (IND)

Anti-angiogenic therapy on in vivo tumor bearing

mouse model System

67. Sanjay Gupta, Ph.D. (USA)

PLANT FLAVONOIDS AS EPIGENETIC MODULATORS

IN CANCER: IMPLICATIONS IN CANCER

CHEMOPREVENTION

68. Sankar Mitra, Ph.D (USA)

TBA

69. Sen Pathak, Ph.D. (USA)

Are telomeres involved in Cancer causation, drug

discovery and prevention?

70. Shailesh Singh (USA)

TBA

71. Sharmila Sengupta, Ph.D (IND)

TBA

72. Sheo Mohan Singh, Ph.D. (IND)

Role of myeloid transcription factors in the

pathogenesis of leukemic cancers

73. Shivendra Singh , Ph.D. (USA)

TBA

74. Shrikant Anant , Ph.D. (USA)

TBA

75. Snigdha Banerjee, Ph.D. (USA)

The role of PDGF-B-NRP-1 signaling in

mesenchymal to pericytes transition during tumor

angiogenesis

76. Soumen Paul, Ph.D. (USA)

Protein Kinase C Signaling: from Embryonic Stem

Cell to Cancer

77. Subash Basu ,PhD, D.Sc (USA)

Probable New Therapeutic Drugs for Breast and

Colon Cancers

78. Subhamoy Dasgupta, PhD (USA)

Steroid Receptor Coactivator in Oncogenic

Reprogramming of Cancer Cell Metabolism.

79. Sujit Basu, MD, Ph.D. (USA)

TBA

80. Suman Kambhampati, MD (USA)

A Second Generation 2-Methoxyestradiol Prodrug

is Effective against Barrett’s Adenocarcinoma in a

Mouse Xenograft Model

81. Sushanta K. Banerjee, Ph.D (USA)

Aspirin in breast carcinogenesis: A friend or foe

82. Tanya Das, Ph.D (IND)

Targeting cancer stem cells: An approach towards

next generation cancer therapy

83. Tapan Chaudhuri, MD (USA)

Introduction to the science of acupuncture and its

application in the realm of Cancer

84. Tapas Kundu, Ph.D (IND)

Epigenetic Modifications as Targets of Cancer

Therapeutics: Implications in Oral Cancer.

85. Thangarajan Rajkumar, Ph.D. (IND)

Targeting EWS-FLT1 fusion protein

86. Theresa Pacheco, Ph.D (USA)

TBA

87. Tony Kong, MD (USA)

Cancer Prevention by Dietary Phytochemicals:

from Nrf2-mediated Anti-Oxidative Stress,

Epigenetics to in vivo Cancer Models

88. Uddhav Kelavkar, PhD

(USA)

Dietary polyunsaturated fatty acids, cancer and

chemoprevention

89. Urmi Chatterji, Ph.D (IND)

Elucidating the molecular signaling adapted by

artemisinin in cervical cancer cells

90. Virginia Savin, MD(USA)

Evaluating renal function in patients

undergoing chemotherapy

91. Xianglin Shi , MD, Ph.D (USA)

Plant-derived antioxidants and disease prevention

92. Xiaolin Zi , PhD (USA)

Epigenetic chemoprevention of tobacco-related

urinary bladder carcinogenesis by Kawain

93. Yogesh C Awasthi, PhD (USA)

TBA